Bedard, P., Call, J. A., Garman, D., Garmey, E. G., Hew, P., Lin, R., LoRusso, P., Lui, F., Saleh, R., Siow, L., Sommerhalder, D., Yap, T. A., Zhai, A., Siu, L. L. (2026). Phase 1, multi-center clinical trial evaluating the safety, pharmacokinetics, pharmacodynamics and anti-cancer activity of PQ203, a first-in-class peptide drug conjugate targeting SORT1 in patients with advanced solid tumor malignancies (NCT07190469).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps3171